惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

L
LangChain Blog
B
Blog RSS Feed
阮一峰的网络日志
阮一峰的网络日志
Cyber Security Advisories - MS-ISAC
Cyber Security Advisories - MS-ISAC
H
Help Net Security
MyScale Blog
MyScale Blog
WordPress大学
WordPress大学
Microsoft Azure Blog
Microsoft Azure Blog
GbyAI
GbyAI
小众软件
小众软件
大猫的无限游戏
大猫的无限游戏
Martin Fowler
Martin Fowler
Vercel News
Vercel News
S
SegmentFault 最新的问题
M
MIT News - Artificial intelligence
Microsoft Security Blog
Microsoft Security Blog
G
Google Developers Blog
Last Week in AI
Last Week in AI
Hugging Face - Blog
Hugging Face - Blog
酷 壳 – CoolShell
酷 壳 – CoolShell
博客园 - 【当耐特】
Google DeepMind News
Google DeepMind News
Engineering at Meta
Engineering at Meta
云风的 BLOG
云风的 BLOG

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Grifols, S.A. (GIKLY) Q1 2026 Earnings Call Transcript
2026-05-10 · via All Articles on Seeking Alpha

Grifols, S.A. (GIKLY) Q1 2026 Earnings Call May 7, 2026 12:30 PM EDT

Company Participants

Daniel Segarra - Head of Investor Relations & Sustainability and Vice President
Jose Ignacio Abia Buenache - CEO & Director
Roland Wandeler - President of Biopharma Business Unit
Rahul Srinivasan - Chief Financial Officer

Conference Call Participants

Charles Pitman - Barclays Bank PLC, Research Division
Jaime Escribano - Banco Santander, S.A., Research Division
Thibault Boutherin - Morgan Stanley, Research Division
Charlie Haywood - BofA Securities, Research Division
Guilherme Sampaio - Caixa Banco BPI., Research Division
Justin Steven Smith - Bernstein Institutional Services LLC, Research Division

Presentation

Daniel Segarra
Head of Investor Relations & Sustainability and Vice President

Hello, everyone, and thank you for joining us today for Grifols First Quarter 2026 Earnings Call. My name is Daniel Segarra, and I serve as the Head of Investor Relations and Sustainability. Today, I'm joined by Grifols's Chief Executive Officer, Nacho Abia; President of Biopharma, Roland Wandeler; and Chief Financial Officer, Rahul Srinivasan.

As is our usual practice, today's call will last about an hour, including the Q&A session. Please note that this call is being recorded. You can find additional materials, including today's presentation in the Investor Relations section of the Grifols website at grifols.com.

A transcript and replay of the webcast will also be available on the Investor Relations website within 24 hours. Turning to Slide 2. I would like to remind everyone that forward-looking statements may be made during this call. This may include, among other things, comments regarding the company's future operating and financial performance, statements about our future expectations, clinical developments, regulatory time lines and the potential success of our product candidates.

These statements are based on current expectations and available information as of the date of this call and are subject to certain risks and uncertainties that may cause